Show simple item record

dc.contributor.authorAdamson, Catherine S
dc.contributor.authorChibale, Kelly
dc.contributor.authorGoss, Rebecca J M
dc.contributor.authorJaspars, Marcel
dc.contributor.authorNewman, David J
dc.contributor.authorDorrington, Rosemary A
dc.date.accessioned2021-02-16T16:04:01Z
dc.date.available2021-02-16T16:04:01Z
dc.date.issued2021-03-21
dc.identifier187921163
dc.identifier244416df-e24d-468b-85a5-bd615ab84df9
dc.identifier33524090
dc.identifier85102078050
dc.identifier000635214300002
dc.identifier000680831100001
dc.identifier85113863453
dc.identifier.citationAdamson , C S , Chibale , K , Goss , R J M , Jaspars , M , Newman , D J & Dorrington , R A 2021 , ' Antiviral drug discovery : preparing for the next pandemic ' , Chemical Society Reviews , vol. 50 , no. 6 , pp. 3647-3655 . https://doi.org/10.1039/d0cs01118e , https://doi.org/10.1039/d1cs90064aen
dc.identifier.issn0306-0012
dc.identifier.urihttps://hdl.handle.net/2164/15878
dc.descriptionAcknowledgements The authors also gratefully acknowledge financial support from the South African Medical Research Council (MRC) with funds received from the South African National Department of Health and the UK Government's Newton Fund (R. A. D., RL. M. G., K. C.), the UK Engineering and Physical Sciences Research Council EQATA (R. J. M. G.), the UK Global Challenge Research Fund (R. J. M. G., R. A. D.), the University of Cape Town (K. C.) and the South African Research Chairs Initiative of the Department of Science and Innovation, administered through the South African National Research Foundation (NRF) to K. C. (UID: 64767) and R. A. D. (UID: 87583). C. S. A. acknowledges financial support for SARS-CoV-2/Covid-19 research from UKMRC (CVG-1725-2020) and UKRI-DHSC (MR/Vo28464/1). The authors acknowledge Bronwyn Tweedie of the Rhodes University Print Services Unit who provided the graphics for Fig. 1 and thank Gordon Cragg for his insightful comments and encouragement during the preparation of this manuscript. Erratum: Antiviral drug discovery: Preparing for the next pandemic (Chem. Soc. Rev.( 2021) 50 (3647–3655) DOI: 10.1039/D0CS01118E)en
dc.format.extent9
dc.format.extent2363691
dc.language.isoeng
dc.relation.ispartofChemical Society Reviewsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAntiviral Agents/chemistryen
dc.subjectBiological Products/chemistryen
dc.subjectCOVID-19/drug therapyen
dc.subjectCoronavirus Protease Inhibitors/chemistryen
dc.subjectDrug Discovery/methodsen
dc.subjectHumansen
dc.subjectMolecular Docking Simulationen
dc.subjectMolecular Targeted Therapy/methodsen
dc.subjectNucleic Acid Synthesis Inhibitors/chemistryen
dc.subjectPandemics/prevention & controlen
dc.subjectRNA, Viral/antagonists & inhibitorsen
dc.subjectSARS-CoV-2/chemistryen
dc.subjectSmall Molecule Libraries/chemistryen
dc.subjectQD Chemistryen
dc.subjectGeneral Chemistryen
dc.subjectMedical Research Council (MRC)en
dc.subjectCVG-1725-2020en
dc.subjectOtheren
dc.subjectMR/Vo28464/1en
dc.subject.lccQDen
dc.titleAntiviral drug discovery : preparing for the next pandemicen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.The Marine Biodiscovery Centreen
dc.contributor.institutionUniversity of Aberdeen.Marine Alliance for Science and Technology for Scotland (MASTS)en
dc.contributor.institutionUniversity of Aberdeen.Chemistryen
dc.description.statusPeer revieweden
dc.identifier.doi10.1039/d0cs01118e
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85102078050&partnerID=8YFLogxKen
dc.identifier.vol50en
dc.identifier.iss6en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record